Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ARCT-2138 by Seqirus for Seasonal Influenza: Likelihood of Approval
ARCT-2138 is under clinical development by Seqirus and currently in Phase I for Seasonal Influenza. According to GlobalData, Phase I...